SCHEMBL2302751

SCHEMBL2302751

CCNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(Cc3ccc(B(O)O)c(C(F)(F)F)c3)S(C)(=O)=O)c(C3CC3)cc12

nearest known ligand 0.73

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.73
CYP3A4 P08684 4/20 0.73
CYP2C19 P33261 4/20 0.73
KCNH2 Q12809 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2298801 0.93 CYP2C9 (0.84) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL2301051 0.92 CYP2C9 (0.65) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL2295943 0.92 CYP2C9 (0.86) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL12423868 0.90 CYP2C9 (0.78) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL12423863 0.87 CYP2C9 (0.74) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL2299496 0.85 CYP2C9 (0.74) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL12422527 0.85 CYP2C9 (0.86) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL29461451 0.85 CYP2C9 (1.00) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL2294370 0.85 CYP2C9 (1.00) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL12422593 0.84 CYP2C9 (0.88) CYP2C9CYP3A4CYP2C19KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011103063-A1 THERAPEUTIC COMPOUNDS GLAXO GROUP LIMITED (GB) 2011-08-25 WO claimed
WO-2011103063-A1 THERAPEUTIC COMPOUNDS GLAXO GROUP LIMITED (GB) 2011-08-25 WO disclosed
WO-2011103063-A1 THERAPEUTIC COMPOUNDS GLAXO GROUP LIMITED (GB) 2011-08-25 WO disclosed